Legal & General Group’s Cassava Sciences SAVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-7,256
| Closed | -$10.9K | – | 3523 |
|
2025
Q1 | $10.9K | Sell |
7,256
-39,112
| -84% | -$58.8K | ﹤0.01% | 3145 |
|
2024
Q4 | $109K | Buy |
46,368
+742
| +2% | +$1.75K | ﹤0.01% | 2716 |
|
2024
Q3 | $1.34M | Sell |
45,626
-2,928
| -6% | -$86.2K | ﹤0.01% | 2126 |
|
2024
Q2 | $600K | Buy |
48,554
+6,531
| +16% | +$80.7K | ﹤0.01% | 2355 |
|
2024
Q1 | $853K | Buy |
42,023
+1,209
| +3% | +$24.5K | ﹤0.01% | 2245 |
|
2023
Q4 | $919K | Buy |
40,814
+3,318
| +9% | +$74.7K | ﹤0.01% | 2241 |
|
2023
Q3 | $624K | Buy |
37,496
+66
| +0.2% | +$1.1K | ﹤0.01% | 2349 |
|
2023
Q2 | $918K | Buy |
37,430
+305
| +0.8% | +$7.48K | ﹤0.01% | 2259 |
|
2023
Q1 | $895K | Buy |
37,125
+2,537
| +7% | +$61.2K | ﹤0.01% | 2178 |
|
2022
Q4 | $1.02M | Sell |
34,588
-143
| -0.4% | -$4.22K | ﹤0.01% | 2151 |
|
2022
Q3 | $1.45M | Buy |
34,731
+365
| +1% | +$15.3K | ﹤0.01% | 2013 |
|
2022
Q2 | $966K | Sell |
34,366
-820
| -2% | -$23.1K | ﹤0.01% | 2174 |
|
2022
Q1 | $1.31M | Buy |
35,186
+1,239
| +4% | +$46K | ﹤0.01% | 2144 |
|
2021
Q4 | $1.48M | Buy |
33,947
+152
| +0.4% | +$6.65K | ﹤0.01% | 2135 |
|
2021
Q3 | $2.1M | Buy |
33,795
+24,849
| +278% | +$1.54M | ﹤0.01% | 2006 |
|
2021
Q2 | $765K | Buy |
8,946
+5,958
| +199% | +$509K | ﹤0.01% | 2259 |
|
2021
Q1 | $134K | Sell |
2,988
-76
| -2% | -$3.41K | ﹤0.01% | 2538 |
|
2020
Q4 | $21K | Buy |
3,064
+708
| +30% | +$4.85K | ﹤0.01% | 3073 |
|
2020
Q3 | $27K | Sell |
2,356
-902
| -28% | -$10.3K | ﹤0.01% | 2884 |
|
2020
Q2 | $10K | Buy |
+3,258
| New | +$10K | ﹤0.01% | 3311 |
|